Law enforcement in six states arrested more people for marijuana than all other drugs combined last year, according to a NORML analysis of FBI Uniform Crime Reporting data released this week.
Idaho, Iowa, Kansas, Louisiana, Nebraska and Wisconsin each dedicated over 50% of their drug arrest resources to cannabis offenses in 2023, despite growing evidence that prohibition policies strain law enforcement budgets without reducing usage rates. The analysis examined arrest data from states that maintain full prohibition on adult-use cannabis.
"In many prohibition states, marijuana arrests continue to consume a disproportionate amount of law enforcement time and taxpayer resources," said Paul Armentano, NORML's Deputy Director, in a statement accompanying the data release. "These arrests do little to advance public safety while creating lasting criminal records that impact employment, housing, and educational opportunities."
The Numbers
The disparities varied by state but painted a consistent picture. In Nebraska, cannabis arrests accounted for 58% of all drug arrests in 2023. Kansas followed at 54%, while Idaho, Iowa, Louisiana and Wisconsin each exceeded the 50% threshold.
These figures stand in sharp contrast to states with legal adult-use markets. California, Colorado and Washington each reported cannabis arrests comprising less than 15% of total drug arrests, with law enforcement resources redirected toward synthetic opioids and methamphetamine trafficking.
The analysis comes as federal rescheduling efforts remain stalled. The DEA's proposed move of marijuana from Schedule I to Schedule III has faced delays, leaving state-level enforcement patterns unchanged even as public opinion shifts toward legalization.
Enforcement Costs
Policy experts point to the financial burden these arrests create. A single marijuana arrest costs taxpayers an estimated $1,000 to $2,000 when accounting for police time, court processing and potential incarceration, according to research from the Drug Policy Alliance.
In Wisconsin alone, where marijuana arrests exceeded 14,000 in 2023, the state likely spent over $20 million on cannabis enforcement. That money could have funded treatment programs or addressed the state's growing fentanyl crisis, critics argue.
"We're seeing prohibition states double down on failed policies while their neighbors demonstrate that regulation works," said Karen O'Keefe, director of state policies at the Marijuana Policy Project. "Illinois and Michigan have legal markets generating hundreds of millions in tax revenue. Meanwhile, Wisconsin is spending millions to arrest people for the same plant."
The racial disparities in these arrests remain pronounced. NORML's analysis noted that Black Americans are arrested for marijuana at nearly four times the rate of white Americans, despite similar usage rates across demographic groups.
What's Next
Legislative efforts in several of these states face steep opposition. Nebraska activists collected signatures for a 2024 ballot measure to legalize medical cannabis, though the initiative faces legal challenges. Iowa's Republican-controlled legislature has repeatedly blocked legalization bills, despite polling showing majority support among voters.
Kansas lawmakers introduced legalization legislation in the 2024 session, but the bill died in committee. Louisiana, which has a limited medical program, saw its legislature reject adult-use proposals for the third consecutive year.
The data arrives as the 2024 election cycle heats up, with cannabis legalization measures likely appearing on ballots in Florida, North Dakota and potentially South Dakota. Industry observers expect the stark enforcement statistics to fuel voter turnout among legalization supporters.
Armentano noted that the arrest figures undercount the full scope of enforcement. "These numbers don't include citations, court summonses or interactions that don't result in formal arrests," he said. "The true footprint of marijuana prohibition is even larger than these FBI statistics suggest."
For businesses operating in legal states, the data underscores the patchwork nature of U.S. cannabis policy. Interstate commerce remains impossible, and companies serving medical patients in states like Louisiana operate under constant threat that enforcement priorities could shift.
This article is based on original reporting by www.marijuanamoment.net.
